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Abstract
The correct targeting of proteins to axons and dendrites of
neurons is essential for the proper development of the nervous
system. L1CAM is an axonally-targeted protein responsible for
multiple aspects of neuronal development. L1CAM mutations
are known to result in a developmental syndrome characterized
by cognitive and motor disabilities. We investigated the cellular
distribution of known L1CAM mutant proteins, P941L and
D544N, in cultured embryonic chick forebrain neurons to test
the hypothesis that aberrant protein targeting of these mutants
plays a role in the developmental abnormalities associated with
the syndrome. Preliminary data suggests that the P941L
L1CAM mutant is targeted normally to the axon suggesting that
downstream signaling events are abnormal. In contrast, the
D544N L1CAM mutant does not appear to reach the cell surface
of the neuron.

Introduction
L1 syndrome is caused by mutations in the L1CAM protein. The
syndrome affects 1 in every 30,000 newborn human males,
characterized by hydrocephalus and seizures in severe cases, as
well as lower-limb muscle spasticity and adducted thumbs.
L1CAM is an axonal protein involved in axon-pathfinding
during neural development, myelination of axons, cell migration,
and transmembrane signaling at tyrosine kinase receptors. The
ectodomain of L1CAM is composed of six immunoglobulin-like
and five fibronectin(III)-like repeats, with a single
transmembrane helical segment and short intracellular Cterminus (Haspel and Grumet, 2003). The severity of L1
syndrome varies with different mutations. The D544N mutation
is localized in the sixth immunoglobulin domain and has been
shown to affect homophilic binding when expressed in nonneural cells (De Angelis, et al. 2002). The P941L mutation is
localized in the fourth fibronectin domain and when expressed in
PC12 cells affects cell migration and neurite outgrowth
(Tagliavacca et al., 2012). The current study investigates the
cellular trafficking and subsequent axonal targeting of mutant
human L1CAM constructs of D544N and P941L.

Materials And Methods
Culture: Chick forebrain neurons were cultured from incubated fertilized eggs between 8-9 days of development.
Forebrains were dissected, treated with trypsin, and dissociated into single cells by trituration in HBSS. The cells were
plated on acid-washed coverslips treated with poly-L-lysine (1 mg/ml) in Neurobasal media with B27.
Transfection: P941L or D544N human L1CAM construct (Addgene) were co-transfected with mRuby via Nucleofection
(Amaxa). 2 µg of each DNA construct were mixed with 100 µl of Nucleofector solution containing 4x106 forebrain cells.
The solution was electroporated using the Nucleofector II and subsequently plated on poly-lysine treated coverslips.
Immunocytochemistry: Transfected cultures were incubated with anti-L1 antibodies (5G3; Novus; 1:200) live for 2-5
minutes at 37oC and then fixed. To visualize internal staining some cultures were incubated for 1 hour at 37oC after
fixation. Endogenous cell-surface NgCAM was labeled using 8D9 (DSHB) antibodies (1:2) live for 2-5 minutes at 37oC
and then fixed. After primary antibody labeling all cultures were then incubated sequentially with FITC-donkey-antimouse secondary antibodies (1:400; Jackson), mouse anti-FITC (1:200; Sigma) and a Dylight488-donkey-anti-mouse
secondary (1:400; Jackson) and visualized.

Results
Figure 1. Micrographs of example neuron cultured among
glial cells illustrating live antibody labeling of endogenous
NgCAM. (A) Phase contrast. (B) Live antibody labeling of
NgCAM. Neurons exhibit polarized expression of NgCAM
to their axons. Faint labeling of dendrites at background
fluorescence levels are observed. (bar=25 µm)
Figure 2. Micrographs of neuron co-transfected with mRuby
and P941L L1CAM mutant (A) Phase contrast. (B) mRuby.
(C) P941L mutant. Live L1CAM antibody labeling is
observed in the axon, branches of which loop around the cell
body and some presumptive dendrites. Arrows indicate a
presumptive dendrite visualized with mRuby that is not
labeled by the L1CAM antibody.
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L1CAM is an axonally-targeted protein responsible for
multiple aspects of neuronal development. The current study
examined the cellular distribution of two L1CAM mutants,
D544N and P941L, in cultured chick embryonic forebrain
neurons. We hypothesized that aberrant protein targeting of
these mutants plays a role in the abnormal developmental
manifestations of L1 syndrome, such as cognitive and motor
disabilities.
Our data suggest that the P941L L1CAM mutant is targeted
normally to the axon suggesting that downstream signaling
events are abnormal. Taggliavacca et al. (2012) reports that
P941L when transfected in PC12 cells reaches the cell surface
but these cells exhibit delays in cell migration and decreased
neurite amount and length compared to wild-type L1CAM.
We hypothesize that the P941L mutant exhibits normal
cellular trafficking and localization but the mutation prevents
its interaction with some relevant protein thereby altering L1mediated signaling.
D544 is a highly conserved surface site among L1
orthologues (De Angelis, 2002). Current literature suggests
that the D544N mutant reduces homophilic L1:L1 binding.
However, our data suggests that the D544N mutant does not
reach the cell surface of the neuron. No immunofluorescence
was observed in embryonic chick forebrain neurons
transfected with the D544N L1CAM mutant when labeled
live with antibody. In contrast, when primary antibody
labeling was done on fixed neurons some faint labeling was
observed in the cell body (Figure 3). We hypothesize that this
mutation causes L1CAM to become trapped inside the
endoplasmic reticulum, and therefore cannot be trafficked to
the plasma membrane of the neuron.

Conclusions & Future Directions

Figure 3: Micrographs of neuron co-transfected with mRuby and D544N L1CAM mutant (A) Phase contrast.
(B) mRuby (C) D544N. L1CAM antibody labeling post-fixing is observed in the cell body. Live labeling of
D544N neurons do not exhibit any appreciable staining suggesting that D544N never reaches the cell surface
(not shown).
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The current study suggests differences in cell-surface
expression among D544N and P941L L1CAM mutants. Live
immunostaining of the L1CAM primary antibody showed
presence of the P941L mutant at the cell surface as well as
axonal localization, but D544N did not appear to reach the
cell surface. Future research will investigate cell-signaling
and protein-protein interactions in these mutants, as well as
examine possible ER localization of D544N.
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